Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD62B is a non-coding RNA belonging to the box C/D family of snoRNAs, characterized by conserved C box (UGAUGA) and D box (CUGA) sequence motifs[1][5]. It resides in the nucleolus of eukaryotic cells and acts as a guide RNA, directing the site-specific 2'-O-methylation of substrate RNAs, especially ribosomal RNA. In humans, SNORD62B (alongside a highly similar copy, SNORD62A) is found within introns of a host gene and is specifically predicted to guide 2'-O-methylation of the 18S rRNA at residue A590[1]. SNORD62B is essential for the proper modification and maturation of ribosomal RNA, but is not a receptor, enzyme, transporter, or direct drug target[1][5]. Although altered snoRNA expression in general can be relevant to diseases such as cancer, there is currently no evidence attributing a direct disease or therapeutic biomarker role to SNORD62B specifically[3][4].
Not applicable (no direct drug targeting or pharmacological modulation described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD62B (SNORD62B).